Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9. Issue 3 (29th November 2022)

• Record Type: Journal Article
• Authors: Liang, Jiaxin; Liu, Qiang; Xia, Longzheng; Lin, Jinguan; Oyang, Linda; Tan, Shiming; Peng, Qiu; Jiang, Xianjie; Xu, Xuemeng; Wu, Nayiyuan; Tang, Yanyan; Su, Min; Luo, Xia; Yang, Yiqing; Liao, Qianjin; Zhou, Yujuan
• Is Part Of: Cancer science. Volume 114:Issue 3(2023)
• Page Start: 822
• Page End: 836
• Publication Date: 2022-11-29
• Subjects: glycolysis -- metabolic reprogramming -- pentose phosphate pathway -- Rac1 -- SOX9; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.15652
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract: Metabolic reprogramming is the survival rule of tumor cells, and tumor cells can meet their high metabolic requirements by changing the energy metabolism mode. Metabolic reprogramming of tumor cells is an important biochemical basis of tumor malignant phenotypes. Ras‐related C3 botulinum toxin substrate 1 (Rac1) is abnormally expressed in a variety of tumors and plays an important role in the proliferation, invasion, and migration of tumor cells. However, the role of Rac1 in tumor metabolic reprogramming is still unclear. Herein, we revealed that Rac1 was highly expressed in colon cancer tissues and cell lines. Rac1 promotes the proliferation, migration, and invasion of colon cancer cells by upregulating SOX9, which as a transcription factor can directly bind to the promoters of HK2 and G6PD genes and regulate their transcriptional activity. Rac1 upregulates the expression of SOX9 through the PI3K/AKT signaling pathway. Moreover, Rac1 can promote glycolysis and the activation of the pentose phosphate pathway in colon cancer cells by mediating the axis of SOX9/HK2/G6PD. These findings reveal novel regulatory axes involving Rac1/SOX9/HK2/G6PD in the development and progression of colon cancer, providing novel promising therapeutic targets. Abstract : We further reveal novel regulatory axes involving Rac1/SOX9/HK2/G6PD in the development and progression of colon cancer.